Education
About Us
Working with TipRanks
Follow Us
Park Ha Biological Technology Co., Ltd. (BYAH)
:BYAH
Total Valuation
Park Ha Biological Technology has a market cap or net worth of $8.73M. The enterprise value is ―.
Market Cap$8.73M
Enterprise Value―
Share Statistics
Park Ha Biological Technology has 33,874,405 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,874,405
Owned by Insiders―
Owned by Institutions0.14%
Financial Efficiency
Park Ha Biological Technology’s return on equity (ROE) is 0.32 and return on invested capital (ROIC) is 30.37%.
Return on Equity (ROE)0.32
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)30.37%
Return on Capital Employed (ROCE)0.51
Revenue Per Employee140.11K
Profits Per Employee28.15K
Employee Count17
Asset Turnover0.77
Inventory Turnover2.73
Valuation Ratios
The current PE Ratio of Park Ha Biological Technology is ―. Park Ha Biological Technology’s PEG ratio is -0.00001.
PE Ratio―
PS Ratio0.00011
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF<0.01
Price to Operating Cash Flow10.50
PEG Ratio-0.00001
Income Statement
In the last 12 months, Park Ha Biological Technology had revenue of 2.38M and earned 478.56K in profits. Earnings per share was 0.02.
Revenue2.38M
Gross Profit2.19M
Operating Income793.71K
Pretax Income793.42K
Net Income478.56K
EBITDA816.40K
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was 361.00M and capital expenditures -3.00M, giving a free cash flow of 358.00M billion.
Operating Cash Flow361.00M
Free Cash Flow358.00M
Free Cash Flow per Share10.57
Dividends & Yields
Park Ha Biological Technology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.19
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)307.71K
Important Dates
Park Ha Biological Technology upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Park Ha Biological Technology as a current ratio of 1.87, with Debt / Equity ratio of 4.67%
Current Ratio1.87
Quick Ratio1.82
Debt to Market Cap0.00
Net Debt to EBITDA-0.58
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Park Ha Biological Technology has paid 314.86K in taxes.
Income Tax314.86K
Effective Tax Rate0.40
Enterprise Valuation
Park Ha Biological Technology EV to EBITDA ratio is -0.58, with an EV/FCF ratio of -0.55.
EV to Sales-0.20
EV to EBITDA-0.58
EV to Free Cash Flow-0.55
EV to Operating Cash Flow-0.50
Balance Sheet
Park Ha Biological Technology has $453.00M in cash and marketable securities with $145.00M in debt, giving a net cash position of $308.00M billion.
Cash & Marketable Securities$453.00M
Total Debt$145.00M
Net Cash$308.00M
Net Cash Per Share$9.09
Tangible Book Value Per Share$0.06
Margins
Gross margin is 91.81%, with operating margin of 33.32%, and net profit margin of 20.09%.
Gross Margin91.81%
Operating Margin33.32%
Pretax Margin33.31%
Net Profit Margin20.09%
EBITDA Margin34.27%
EBIT Margin33.32%
Analyst Forecast
The average price target for Park Ha Biological Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―